https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)2012-06-01 00:00:002021-08-09 07:54:41Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-01 / Bull Cancer 2012 Jun;99(6):635-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-01 / Bull Cancer 2012 Jun;99(6):635-422012-06-01 00:00:002019-02-15 08:45:25[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-01 / Semin. Oncol. 2012 Jun;39(3):287-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-01 / Semin. Oncol. 2012 Jun;39(3):287-952012-06-01 00:00:002019-02-15 08:39:56Dendritic/tumor fusion cells as cancer vaccines
